2022 Q1 Form 10-Q Financial Statement

#000156459022019731 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $566.2K $165.2K
YoY Change 242.83% 3938.14%
Cost Of Revenue $532.9K $72.78K
YoY Change 632.19% 0.1%
Gross Profit $33.32K $92.38K
YoY Change -63.93% -234.63%
Gross Profit Margin 5.88% 55.93%
Selling, General & Admin $821.3K $561.7K
YoY Change 46.21% 707.96%
% of Gross Profit 2464.78% 608.04%
Research & Development $1.406M $728.0K
YoY Change 93.17% 356.55%
% of Gross Profit 4220.65% 788.09%
Depreciation & Amortization $16.67K $12.87K
YoY Change 29.45% -77.12%
% of Gross Profit 50.02% 13.94%
Operating Expenses $2.228M $1.290M
YoY Change 72.72% 463.24%
Operating Profit -$2.211M -$1.210M
YoY Change 82.69% 242.01%
Interest Expense -$2.086M $3.056M
YoY Change -168.27% -52.89%
% of Operating Profit
Other Income/Expense, Net -$2.086M $3.057M
YoY Change -168.26% -54.69%
Pretax Income -$4.297M $1.846M
YoY Change -332.74% -71.12%
Income Tax
% Of Pretax Income
Net Earnings -$4.297M $1.846M
YoY Change -332.74% -71.12%
Net Earnings / Revenue -758.95% 1117.94%
Basic Earnings Per Share -$0.20 $0.51
Diluted Earnings Per Share -$0.20 $0.05
COMMON SHARES
Basic Shares Outstanding 21.67M 18.17B
Diluted Shares Outstanding 21.67M 162.6B

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.028M $3.658M
YoY Change -17.22%
Cash & Equivalents $3.028M $3.658M
Short-Term Investments
Other Short-Term Assets $659.5K $108.2K
YoY Change 509.73% 148.44%
Inventory $637.6K $664.8K
Prepaid Expenses
Receivables $561.3K $17.64K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.887M $4.449M
YoY Change 9.84% 703.7%
LONG-TERM ASSETS
Property, Plant & Equipment $325.2K $16.04K
YoY Change 1927.18% -99.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $97.67K
YoY Change
Other Assets $625.0K $625.0K
YoY Change 0.0%
Total Long-Term Assets $5.946M $6.528M
YoY Change -8.92% 30.78%
TOTAL ASSETS
Total Short-Term Assets $4.887M $4.449M
Total Long-Term Assets $5.946M $6.528M
Total Assets $10.83M $10.98M
YoY Change -1.32% 97.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.6K $622.7K
YoY Change -3.54% -54.56%
Accrued Expenses $2.552M $2.242M
YoY Change 13.79% 15.32%
Deferred Revenue
YoY Change
Short-Term Debt $250.0K $443.2K
YoY Change -43.59% -96.24%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.447M $3.341M
YoY Change 3.19% -86.22%
LONG-TERM LIABILITIES
Long-Term Debt $946.1K $7.961M
YoY Change -88.12%
Other Long-Term Liabilities $4.377M $5.035M
YoY Change -13.07% 23719.44%
Total Long-Term Liabilities $5.323M $13.00M
YoY Change -59.04% 61377.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.447M $3.341M
Total Long-Term Liabilities $5.323M $13.00M
Total Liabilities $8.771M $16.34M
YoY Change -46.31% -32.66%
SHAREHOLDERS EQUITY
Retained Earnings -$419.9M
YoY Change 0.7%
Common Stock $1.835M
YoY Change 285.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.062M -$5.360M
YoY Change
Total Liabilities & Shareholders Equity $10.83M $10.98M
YoY Change -1.32% 97.95%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$4.297M $1.846M
YoY Change -332.74% -71.12%
Depreciation, Depletion And Amortization $16.67K $12.87K
YoY Change 29.45% -77.12%
Cash From Operating Activities -$2.792M -$2.009M
YoY Change 38.96% 705.51%
INVESTING ACTIVITIES
Capital Expenditures -$57.45K -$20.00K
YoY Change 187.25%
Acquisitions
YoY Change
Other Investing Activities -$83.87K $17.65K
YoY Change -575.18% -93.06%
Cash From Investing Activities -$141.3K $17.65K
YoY Change -900.76% -93.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 5.500M
YoY Change -100.0% -110100.0%
NET CHANGE
Cash From Operating Activities -2.792M -2.009M
Cash From Investing Activities -141.3K 17.65K
Cash From Financing Activities 0.000 5.500M
Net Change In Cash -2.933M 3.491M
YoY Change -184.03%
FREE CASH FLOW
Cash From Operating Activities -$2.792M -$2.009M
Capital Expenditures -$57.45K -$20.00K
Free Cash Flow -$2.735M -$1.989M
YoY Change 37.47% 697.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0002
CY2022Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0002
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
532890
CY2021Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
72782
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1406322
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
728036
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
821266
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
561709
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16665
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12872
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
2777143
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1375399
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2210933
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1210241
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
800
CY2022Q1 asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
2086314
CY2021Q1 asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
562079
CY2021Q1 asti Gain Loss On Derivative And Extinguishment Of Debt Net
GainLossOnDerivativeAndExtinguishmentOfDebtNet
3617904
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2086314
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3056625
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4297249
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-20192203
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2500000
CY2021Q1 asti Stock Issued During Period Value Of Common Stock
StockIssuedDuringPeriodValueOfCommonStock
3000000
CY2021Q1 asti Adjustments To Additional Paid In Capital Relieved On Conversion Of Derivative Liability
AdjustmentsToAdditionalPaidInCapitalRelievedOnConversionOfDerivativeLiability
1686079
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1846384
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-5359740
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4297249
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16665
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12874
CY2022Q1 asti Operating Lease Asset Amortization
OperatingLeaseAssetAmortization
168671
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
161592
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1846384
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-7097
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4304346
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1846384
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4297249
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-7097
CY2021Q1 asti Operating Lease Asset Amortization
OperatingLeaseAssetAmortization
158502
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2069206
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
542164
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2
CY2021Q1 asti Warranty Reserve
WarrantyReserve
-463
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3617904
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
512004
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12100
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
45448
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
130369
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
411802
CY2022Q1 asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
-41565
CY2021Q1 asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
-96691
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-103334
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-157479
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-140105
CY2022Q1 asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
15107
CY2021Q1 asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
5413
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
403816
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-312073
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2792080
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2009294
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
83559
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
57451
CY2022Q1 asti Proceeds From Payments To Patent Activity
ProceedsFromPaymentsToPatentActivity
-308
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-141318
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5500000
CY2022Q1 asti Series One A Preferred Stock Conversion
SeriesOneAPreferredStockConversion
740
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5500000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2933398
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3490706
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5961760
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167725
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3028362
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3658431
CY2022Q1 asti Conversion Of Stock To Equity Amount
ConversionOfStockToEquityAmount
9200000
CY2021Q1 asti Conversion Of Stock To Equity Amount
ConversionOfStockToEquityAmount
5800000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Stockholders Equity Note Changes In Capital Structure Retroactive Impact
StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpact
Following the Reverse Stock Split, the Company’s issued and outstanding shares of Common Stock were decreased from approximately 23.7 billion pre-split shares to 4.8 million post-split shares. In connection with the Reverse Stock Split effectiveness, the number of authorized shares of the Company's Common Stock were decreased from 30 billion to 500 million shares.
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
22500
CY2022Q1 asti Additions Of Deferred Revenue
AdditionsOfDeferredRevenue
198500
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-22500
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
198500
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32500000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
279662
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2792080
CY2022Q1 asti Working Capital
WorkingCapital
1439461
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22483386
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22425935
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22158146
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22146273
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
325240
CY2021Q1 us-gaap Depreciation
Depreciation
2724
CY2022Q1 asti Number Of Rentable Square Feet Of Building
NumberOfRentableSquareFeetOfBuilding
100000
CY2022Q1 us-gaap Depreciation
Depreciation
11873
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
646742
CY2022Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The lease is classified as an operating lease and accounted for accordingly. The Lease term is for 88 months commencing on September 21, 2020 at a rent of $50,000 per month including taxes, insurance and common area maintenance until December 31, 2020. Beginning January 1, 2021, the rent adjusted to $80,000 per month on a triple net basis and shall increase at an annual rate of 3% per annum until December 31, 2027.
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P88M
CY2020Q3 asti Lease Commencement Date
LeaseCommencementDate
2020-09-21
CY2020Q3 us-gaap Lease Cost
LeaseCost
50000
CY2021Q1 us-gaap Lease Cost
LeaseCost
80000
CY2022Q1 asti Percentage Of Rent Increase In Annual Rate
PercentageOfRentIncreaseInAnnualRate
0.03
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4816017
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4984688
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
665585
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4356168
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4532490
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
258392
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
258393
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
741600
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1018464
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1049018
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1080488
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1112903
CY2022Q1 asti Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1146290
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6148763
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1127010
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P69M15D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
592300
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
575154
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
41619
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15803
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3700
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1215
CY2022Q1 us-gaap Inventory Net
InventoryNet
637620
CY2021Q4 us-gaap Inventory Net
InventoryNet
592172
CY2021Q4 asti Short Term Debt Gross
ShortTermDebtGross
10400000
CY2022Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
CY2022Q1 asti Debt Instrument Increase Decrease Amount Redocumented Or Assigned
DebtInstrumentIncreaseDecreaseAmountRedocumentedOrAssigned
0
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
9200000
CY2022Q1 asti Short Term Debt Gross
ShortTermDebtGross
1200000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
253947
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
946053
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 asti Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30586804
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001

Files In Submission

Name View Source Status
0001564590-22-019731-index-headers.html Edgar Link pending
0001564590-22-019731-index.html Edgar Link pending
0001564590-22-019731.txt Edgar Link pending
0001564590-22-019731-xbrl.zip Edgar Link pending
asti-10q_20220331.htm Edgar Link pending
asti-10q_20220331_htm.xml Edgar Link completed
asti-20220331.xsd Edgar Link pending
asti-20220331_cal.xml Edgar Link unprocessable
asti-20220331_def.xml Edgar Link unprocessable
asti-20220331_lab.xml Edgar Link unprocessable
asti-20220331_pre.xml Edgar Link unprocessable
asti-ex311_10.htm Edgar Link pending
asti-ex312_8.htm Edgar Link pending
asti-ex321_6.htm Edgar Link pending
asti-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending